We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$15.2B
AUM Growth
+$50.6M
(+0.33%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
39.77%
Holding
1,536
New
117
Increased
196
Reduced
365
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$64.7M |
| 2 |
Oracle
ORCL
|
+$59M |
| 3 |
Leidos
LDOS
|
+$54.6M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$37.3M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$53.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$53.2M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.6M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$31.4M |
| 5 |
Allison Transmission
ALSN
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.01% |
| 2 | Healthcare | 11.19% |
| 3 | Industrials | 8.55% |
| 4 | Technology | 7.57% |
| 5 | Energy | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Coca-Cola
KO
$349B
| $41.7M | 0.28% |
1,079,839
-14,558
| -1% | -$562K |
|
77
AutoZone
AZO
$47.7B
| $40.1M | 0.26% |
74,710
+5,294
| +8% | +$2.75M |
|
78
Darden Restaurants
DRI
$22.2B
| $40M | 0.26% |
880,996
+88,446
| +11% | +$3.96M |
|
79
UnitedHealth
UNH
$385B
| $38.5M | 0.25% |
469,017
-63
| -0% | -$4.74K |
|
|
PX
80
DELISTED
Praxair Inc
PX
| $37.5M | 0.25% |
286,310
-2,002
| -0.7% | -$259K |
|
81
Walt Disney
DIS
$161B
| $37.3M | 0.25% |
465,535
-8,602
| -2% | -$667K |
|
82
Amgen
AMGN
$201B
| $36.8M | 0.24% |
298,261
+4,976
| +2% | +$603K |
|
83
Ingredion
INGR
$6.32B
| $36.6M | 0.24% |
537,039
-11,452
| -2% | -$751K |
|
84
Brookfield Infrastructure Partners
BIP
$18.9B
| $36.3M | 0.24% |
2,317,573
+156,076
| +7% | +$2.33M |
|
|
FRX
85
DELISTED
FOREST LABORATORIES INC
FRX
| $36.3M | 0.24% |
392,989
-404,450
| -51% | -$32.6M |
|
86
Williams Companies
WMB
$92B
| $35.3M | 0.23% |
869,324
-6,450
| -0.7% | -$261K |
|
|
TECD
87
DELISTED
Tech Data Corp
TECD
| $35.1M | 0.23% |
576,083
-6,660
| -1% | -$369K |
|
88
Western Union
WU
$2.6B
| $34.6M | 0.23% |
2,114,647
-14,198
| -0.7% | -$231K |
|
|
QVCGA
89
DELISTED
QVC Group Inc Series A
QVCGA
| $33M | 0.22% |
27,793
-813
| -3% | -$950K |
|
90
Innoviva
INVA
$1.56B
| $31.9M | 0.21% |
1,278,201
+488,888
| +62% | +$14.3M |
|
91
Minerals Technologies
MTX
$2.27B
| $31.4M | 0.21% |
485,834
-2,700
| -0.6% | -$153K |
|
92
Teva Pharmaceuticals
TEVA
$36.3B
| $31.2M | 0.21% |
590,520
+3,596
| +0.6% | +$166K |
|
93
The Mosaic Company
MOS
$7.08B
| $31.1M | 0.2% |
621,431
+15,434
| +3% | +$735K |
|
|
RTN
94
DELISTED
Raytheon Company
RTN
| $30.6M | 0.2% |
309,702
-37,160
| -11% | -$3.53M |
|
|
SFE
95
DELISTED
Safeguard Scientifics, Inc.
SFE
| $30.4M | 0.2% |
1,370,284
-57,599
| -4% | -$1.14M |
|
96
AbbVie
ABBV
$454B
| $30.2M | 0.2% |
587,319
-24,081
| -4% | -$1.22M |
|
97
Mondelez International
MDLZ
$77.1B
| $30M | 0.2% |
867,899
-1,782
| -0.2% | -$60.9K |
|
98
Lowe's Companies
LOW
$113B
| $29.9M | 0.2% |
611,005
-3,402
| -0.6% | -$164K |
|
|
DNB
99
DELISTED
Dun & Bradstreet
DNB
| $29.7M | 0.2% |
298,669
+4,000
| +1% | +$421K |
|
|
AGU
100
DELISTED
Agrium
AGU
| $29.5M | 0.19% |
302,112
-3,150
| -1% | -$288K |
|
Similar funds
SAM
First Manhattan's Q1 2014 Portfolio in Review
As of Q1 2014, First Manhattan held 1,536 positions worth $15.2B, up 0.33% from $15.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
First Manhattan's Q1 2014 filing shows 117 new, 196 increased, 365 reduced and 83 closed positions. Its largest new stake was Leidos: 1,228,013 shares worth $43.4M. The largest sale was Ameren, an estimated $53.3M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q1 2014 buy was Leidos: 1,228,013 shares worth $43.4M.
- First Manhattan added most to Citigroup in Q1 2014, an estimated $64.7M increase.
- First Manhattan's biggest Q1 2014 reduction was Ameren, cutting an estimated $53.3M.
- First Manhattan fully exited Aegerion Pharmaceuticals in Q1 2014, selling an estimated $18.7M.
- First Manhattan's ten largest holdings make up 40% of its $15.2B portfolio in Q1 2014.
- First Manhattan opened 117 new positions and closed 83 in Q1 2014.
- First Manhattan's portfolio value rose 0.33% quarter-over-quarter to $15.2B.
Based on First Manhattan's 13F filing for Q1 2014, filed 16 May 2014.